Exhibit 5.4
[Letterhead of Snell & Wilmer L.L.P.]
October 5, 2020
Encompass Health Corporation
9001 Liberty Parkway
Birmingham, Alabama 35242
Ladies and Gentlemen:
We have acted as special counsel to WellCare, Inc., a New Mexico corporation (“WellCare”) and a subsidiary of Encompass Health Corporation, a Delaware corporation (the “Company”), in connection with the guarantee by WellCare and the other Guarantors (as defined below) of the $400,000,000 aggregate principal amount of the Company’s 4.625% Senior Notes due 2031 (the “Notes”). The Notes are being issued under an Indenture (the “Base Indenture”) between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), dated as of December 1, 2009, as amended and supplemented by the Tenth Supplemental Indenture thereto (the “Supplemental Indenture”), dated as of October 5, 2020 relating to the Notes, among the Company, the guarantors named therein (the “Guarantors”) and the Trustee. The Base Indenture, as amended and supplemented by the Supplemental Indenture, is referenced herein as the “Indenture.” The Notes are being guaranteed by the Guarantors pursuant to the guarantees included in the Indenture (the “Guarantees”), and are being sold pursuant to an Underwriting Agreement dated as of September 30, 2020 (the “Underwriting Agreement”), among the Company, the Guarantors, and Truist Securities, Inc. as representative of the underwriters listed on Schedule 1 to the Underwriting Agreement.
This opinion is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of 1933, as amended (the “Securities Act”). This opinion is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated.
In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of:
| 1. | the registration statement on Form S-3 (Registration No. 333-248942) filed by the Company and the co-registrants named therein with the Securities and Exchange Commission (the “Commission”) under the Securities Act on September 21, 2020 (such registration statement, including the form of prospectus included therein and the documents incorporated by reference therein at the time of effectiveness pursuant to Rule 430B under the Securities Act, being referred to herein as the “Registration Statement”); |
| 2. | the prospectus dated September 21, 2020, included in the Registration Statement, relating to the offering from time to time of the Company’s securities and the related guarantees of the co-registrants (the “Base Prospectus”); |
| 3. | the preliminary prospectus supplement dated September 30, 2020, relating to the Notes, in the form filed on September 30, 2020, with the Commission, pursuant to Rule 424(b)(5) under the Securities Act; |
| 4. | the prospectus supplement dated September 30, 2020, relating to the Notes, in the form filed on October 1, 2020, with the SEC, pursuant to Rule 424(b)(5) under the Securities Act (such prospectus supplement, together with the Base Prospectus, being referred to herein as the “Prospectus”); |
| 5. | the Underwriting Agreement; |